Detected ·
T-Therapeutics Ltd
£100MSeries B
T-Therapeutics Ltd closes a £100M Series B led by Advent Life Sciences and British Business Bank to advance its cancer and autoimmune treatments into clinical trials.
- Website
- www.t-therapeutics.com
- linkedin.com/company/93112302
- Amount
- £100 000 000 GBP
- Stage
- Series B
- Event
- Funding round
- Detected
- 2026-11-05 12:06:55 UTC
- Signal ID
- 5a6ea6b8-fcf8-430c-b3a7-bbf89566ec59
As the API returns it
{
"id": "5a6ea6b8-fcf8-430c-b3a7-bbf89566ec59",
"created_at": "2026-11-05T12:06:55.019078Z",
"company_name": "T-Therapeutics Ltd",
"company_website_url": "www.t-therapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/93112302",
"event_type": "funding",
"funding_amount": 100000000,
"funding_currency": "GBP",
"funding_stage": "series_b",
"message": "*T-Therapeutics Ltd closes a £100M Series B led by Advent Life Sciences and British Business Bank to advance its cancer and autoimmune treatments into clinical trials.*"
}